article thumbnail

The Financialization of Disruptive Technology

The Agile Manager

A recent FT Lex article on biotech investing drives the point home: "A 20-year study found only one-fifth of exits were profitable. The whole point of the portfolio model applied to captive technology investing was to avoid taking a long position in any one thing. Investment yields are highly concentrated. Picking winners is hard.

article thumbnail

What I Read in 2017

Tim Kadlec

It’s fascinating to read about the different ways our technology-reliant world is vulnerable to attacks. Goodman doesn’t pull any punches, and he spends maybe 80% of the book outlining all the various technologies and how they leave us vulnerable. The setting is imaginative and full of unique biotech.

BioTech 45